Trial intelligence / Profile preview

TRK-820 (nalfurafine) soft capsules in refractory pruritus in peritoneal dialysis patients

jRCT2080222514Phase 3

Sponsor
Toray Industries
Start
Jun 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of nalfurafine in pruritus, sponsored by Toray Industries.

02

Drugs

nalfurafine
03

Conditions

pruritus

Beyond the preview

Go deeper on jRCT2080222514.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080222514.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call